Xvivo Perfusion AB

XVIVO

Company Profile

  • Business description

    Xvivo Perfusion AB is a medical technology company dedicated to extending the life of organs so transplant teams around the world can save more lives. Its solutions allow clinicians and researchers to push the boundaries of transplantation medicine. It operates in three segments, namely Thoracic: sales of lung and heart transplant products; Abdominal: sales of liver and kidney transplant products and perfusion services; and Services: revenue from the sale of services related to organ recovery, as well as digital products for communication and workflow management at transplantation clinics. The majority of revenue is derived from the Thoracic segment, and geographically, the majority is from the United States.

  • Contact

    Gemenskapens gata 9
    MolndalSE-431 53
    SWE

    T: +46 317882150

    https://www.xvivoperfusion.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2026

    Employees

    199

Stocks News & Analysis

stocks

Fair value lifts for toll road operator as Aussie fuel supply steadies

An Australian fuel shortage is becoming increasingly unlikely, a relief for ASX toll road operator.
stocks

These overvalued stocks are probably in your portfolio

Priced for perfection.
stocks

Wide moat stock exchange remains cheap

Aussie stock exchange remains materially undervalued despite growing cost concerns.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,969.8023.200.26%
CAC 408,146.5936.75-0.45%
DAX 4025,003.04101.66-0.40%
Dow JONES (US)51,070.5038.040.07%
FTSE 10010,338.9570.33-0.68%
HKSE25,398.18215.790.86%
NASDAQ27,155.17182.550.68%
Nikkei 22566,934.33604.830.91%
NZX 50 Index13,244.5538.440.29%
S&P 5007,612.4532.390.43%
S&P/ASX 2008,729.4019.400.22%
SSE Composite Index4,057.7410.83-0.27%

Market Movers